Clinical Trial Record

Return to Clinical Trials

Pancreatoduodenectomy in Pancreatic and Periampullary Tumors


2016-02


2018-12-19


2018-12-19


154

Study Overview

Pancreatoduodenectomy in Pancreatic and Periampullary Tumors

Background: Recently it has been observed in pancreatic cancer that after apparently complete surgical resection, histological examination of the surgical specimen according to a standard protocol reveals tumor infiltration of the surgical margin in more than 50% of patients. To increase the resection margin and reduce such high infiltration rate, a new surgical approach based on the initial dissection of the superior mesenteric artery has been advocated. Aims: To compare the rate of free resection margin (R0) and oncological results of two possible approaches to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area: the classic approach versus the initial approach of the superior mesenteric artery. Methodology: Prospective, randomized, multicenter study in which patients with pancreatic and periampullary tumors undergo a pancreaticoduodenectomy. In a group the classical approach from the superior mesenteric vein will be performed and in the other group an initially dissecting the superior mesenteric artery approach will be carried out. 116 patients are required and the main variables considered are: free margin rates (R0) or infiltrated by tumor (R1), postoperative morbidity, mortality, local and systemic recurrence, disease-free interval and survival at 1, 3 and 5 years.

N/A

  • Pancreatic and Periampullary Tumors
  • PROCEDURE: Superior mesenteric artery approach for pancreatoduodenectomy
  • PROCEDURE: Classic approach for pancreatoduodenectomy
  • DUOPAN-EPAM

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2016-05-23  

N/A  

2020-07-21  

2016-06-14  

N/A  

2020-07-22  

2016-06-17  

N/A  

2018-02  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
Single


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Superior mesenteric artery approach

Initial approach of the superior mesenteric artery to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area

PROCEDURE: Superior mesenteric artery approach for pancreatoduodenectomy

  • Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the superior mesenteric artery approach
ACTIVE_COMPARATOR: Classic approach

Classic approach to perform a pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area

PROCEDURE: Classic approach for pancreatoduodenectomy

  • Pancreaticoduodenectomy in tumors of the head of the pancreas and peripancreatic area using the classical approach
Primary Outcome MeasuresMeasure DescriptionTime Frame
Rate of free resection margin (R0)Histological examination of the surgical specimen1 month
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients with pancreatic and periampullary tumors undergo a pancreaticoduodenectomy

  • Exclusion Criteria:

  • Patients with hepatic or peritoneal metastasis
  • Patients with irresectable tumor
  • Patients with R2 resection
  • Patients Grade IV of the American Society of Anesthesiology Score
  • Patients with neoadjuvant treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • Instituto de Salud Carlos III

  • : ,

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Sabater L, Cugat E, Serrablo A, Suarez-Artacho G, Diez-Valladares L, Santoyo-Santoyo J, Martin-Perez E, Ausania F, Lopez-Ben S, Jover-Navalon JM, Garces-Albir M, Garcia-Domingo MI, Serradilla M, Perez-Aguirre E, Sanchez-Perez B, Di Martino M, Senra-Del-Rio P, Falgueras-Verdaguer L, Carabias A, Gomez-Mateo MC, Ferrandez A, Dorcaratto D, Munoz-Forner E, Fondevila C, Padillo J. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial. Ann Surg. 2019 Nov;270(5):738-746. doi: 10.1097/SLA.0000000000003535.